The term real-world evidence (RWE) is commonly used to refer to non-randomized clinical trial (RCT) data generated in a healthcare setting, which sometimes extends to cover patient socio-economic data and environmental data. Irrespective of the definition, RWE is seen to offer significant advantages over randomized controlled trials (RCTs), which despite being recognized as the gold […]
Missing data are a big concern in any research project; however, despite investigators’ best efforts they are often unavoidable. Missing outcomes have two effects: they reduce precision and power, and they may introduce bias. The statistician can’t do much about the loss of precision, except to make best use of the data that are available; […]
Workshop title – “R WE Ready?” – “Real World Evidence” Methods! Organisers – Co-organised by Organisation of Pharmaceutical Producers of India (OPPI) and ISPOR India-Mumbai Chapter Objectives – To enhance skill set of the professionals of the medical affairs community in area of real world evidence generation to […]
We all want safe and effective medicines to reach patients as soon as possible, but as we know, drug development, market authorization and payer assessment are all slow sections of a long and drawn out journey for a drug. But what if patients could have access to medicines not just months earlier, but potentially 8 […]
